Clinical Chemistry Pipeline Report Featuring Almost 200 Companies/Universities by Stages of Development, Segments, Region and Countries, Regulatory Path
Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Clinical Chemistry Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" report has been added to ResearchAndMarkets.com's offering.
The report offers an in-depth analysis of the clinical chemistry sector, focusing on products currently under development. It includes detailed descriptions of major pipeline products, their potential applications, and the collaborative and licensing efforts that are steering their development paths. This comprehensive overview provides essential insights into the technologies poised to redefine standards in clinical chemistry diagnostics.
Clinical Chemistry segment comprises of reagents, test kits and electrodes which aid in determining the concentration or activity of biomolecules, such as protein, carbohydrate, lipid, enzyme, minerals or other small molecules.
In addition to product specifics, the report evaluates the major players in the clinical chemistry field, enumerating their ongoing projects. This exploration not only sheds light on the competitive landscape but also highlights the various strategic directions companies are taking to innovate and secure market positioning.
The document categorizes pipeline products based on their stages of development, from early development to those that have already been approved or issued. This categorization helps stakeholders gauge the maturity of different products and their timelines for potential market entry.
Key clinical trial data pertaining to ongoing trials for these products is included, offering vital information on their efficacy and safety. This data is crucial for stakeholders to assess the potential impact of these products on clinical practices.
Furthermore, the report captures recent developments in the clinical chemistry segment, including technological advancements, regulatory changes, and significant industry movements. This information is invaluable for anyone looking to keep up with the latest trends and understand the evolving landscape of clinical chemistry diagnostics.
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Clinical Chemistry under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Key Topics Covered:
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Clinical Chemistry Overview
3 Products under Development
3.1 Clinical Chemistry - Pipeline Products by Stage of Development
3.2 Clinical Chemistry - Pipeline Products by Segment
3.3 Clinical Chemistry - Pipeline Products by Territory
3.4 Clinical Chemistry - Pipeline Products by Regulatory Path
3.5 Clinical Chemistry - Pipeline Products by Estimated Approval Date
3.6 Clinical Chemistry - Ongoing Clinical Trials
4 Clinical Chemistry - Pipeline Products under Development by Companies
4.1 Clinical Chemistry Companies - Pipeline Products by Stage of Development
4.2 Clinical Chemistry - Pipeline Products by Stage of Development
5 Clinical Chemistry Companies and Product Overview
6 Clinical Chemistry- Recent Developments
7 Appendix
A selection of companies mentioned in this report includes, but is not limited to:
- 20/20 GeneSystems Inc
- A.Menarini Diagnostics Ltd
- A/C Diagnostics LLC
- Abbott Diagnostics
- Abreos Biosciences Inc
- ADA Technologies, Inc.
- Adaptive Biotechnologies Corp
- Advanced Biological Laboratories SA
- Affinergy LLC
- Age Labs AS
- Alfa Wassermann Diagnostic Technologies, LLC
- Alfa Wassermann Inc
- Analyticon Biotechnologies AG
- AnaZyme LLC
- Angle Biosciences Inc
- Animated Dynamics Inc
- Antibody Solutions Inc
- Ap Lifesciences LLC
- Applied Research using OMIC Sciences SL
- Arizona State University
- ARK Diagnostics Inc
- Augurix SA
- Avacta Group Plc
- Base Pair Biotechnologies Inc
- BG Medicine Inc
- Biocross SL
- Bioftalmik Applied Research
- BIOHOPE Scientific SL
- BioMarin Pharmaceutical Inc
- Bio-Rad Laboratories Inc
- Biostarks Labs US Inc
- Biotech Resources Aust Pty Ltd
- Bisu Inc
- Boditech Med Inc
- Boston University
- Burnet Institute
- California Pacific Medical Center Research Institute
- Calmark Sweden AB
- Cambridge Diagnostic Imaging Ltd
- Cambridge Nutranostics Ltd
- Carclo Diagnostic Solutions Ltd
- CardioGenics Inc
- CCC Diagnostics LLC
- Cellex Inc
- Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine
- Centre Hospitalier Universitaire de Nice
- Charite University Hospital of Berlin
- Chemeleon Inc
- China Sky One Medical Inc
- ChromaDex Inc
- Chromanostics Inc
- Chronix Biomedical Inc
- Claremont BioSolutions
- Clemson University
- Clinical Design Technologies Ltd
- Cognizance Biomarkers LLC
- Columbia University
- ContraVac Inc (Inactive)
- CytoVas LLC
- Denovo Biolabs Pvt Ltd
- DiaSys Diagnostic Systems GmbH
- DNAPrint Genomics Inc (Inactive)
- DoacLevel
- Dublin City University
- Ecole Polytechnique Federale de Lausanne
- Edan Instruments Inc
- EKF Diagnostics Holdings Plc
- ELITechGroup Inc
- Eurobio Scientific SA
- First Light Diagnostics Inc
- Fluoresprobe Sciences LLC
- Foundation for Innovative New Diagnostics
- Gene Express, Inc. (Inactive)
- genedrive plc
- GenMark Diagnostics Inc
- GlucoSentient Inc
- Group K Diagnostics
- Guangzhou Wondfo Biotech Co Ltd
- Healthy io Ltd
- HORIBA ABX SAS
- Imperial College London
- In Vitro Diagnostic Solutions Inc
- Indian Institute of Technology Delhi
- Inflammatix Inc
- Insilixa, Inc.
- Instrumentation Laboratory Co (Inactive)
- IPI Singapore
- IR2Dx Inc.
- IRIS International Inc
- iXensor Co. Ltd.
- Johns Hopkins University
- Kalium Health Ltd
- Kobe University
- Kwandong University College of Medicine
- L'epigeneMD Co Ltd
- Laboratorios Rubio SA
- LifeAssays AB
- LumiraDx Ltd
- Magee-Womens Research Institute
- Magnasense AB
- Massachusetts Institute of Technology
- McMaster University
- Medical Research Council
- Metabolon Inc
- Miami VA Healthcare System
- MiCo BioMed Co Ltd
- Monash University
- Montana State University
- Mylab Discovery Solutions Pvt Ltd
- Myotherapeutics LLC (Inactive)
- NanoSpeed Diagnostics Inc
- Newcastle University
- Nipro Europe N.V.
- Northeastern University
- Nuclea Biotechnologies Inc. (Inactive)
- Ohmx Corp
- OPKO Health Inc
- Overture Life Inc
- Oxford Immunotec Ltd
- PanGenomic Health Inc
- Pax Neuroscience Inc
- Pelago Bioscience AB
- Pennsylvania State University
- Plateletdiagnostics LLC
- Polomar Health Services Inc
- PortaScience Inc
- Predict Health LLC
- Prediction Sciences LLC (Inactive)
- Prescient Medical Inc
- Primogen Biotech Pvt Ltd
- ProciseDx LLC
- Progenika Biopharma SA
- Prometheus Laboratories Inc
- Proteomika (Inactive)
- Purdue University
- Qiagen NV
- QSTAG Co Ltd
- Queen Mary University of London
- Quidel Corp
- Raptamer Discovery Group LLC
- redhot diagnostics AB
- RenalGuard Solutions, Inc.
- Roche Diagnostics Corp
- Roche Diagnostics International Ltd
- Rockland Immunochemicals Inc
- SAGA Diagnostics AB
- Saladax Biomedical Inc
- SaltCheck Inc (Inactive)
- Sanofi
- Seattle Children's Hospital
- Sebia
- SenGenix Inc
- Shenzhen Mindray Bio-Medical Electronics Co Ltd
- Shilpa Medicare Ltd
- Siemens Healthcare Diagnostics Inc
- Singapore General Hospital
- Sirius Genomics Inc
- Spanish National Research Council
- Specto Srl
- SpinChip Diagnostics AS
- SQI Diagnostics Inc
- Stanford University
- SuperNova Diagnostics, Inc.
- Sysmex Astrego AB
- Systagenix Wound Management Ltd
- T2 Biosystems Inc
- Teco Diagnostics
- TestCard Ltd
- The Chinese University of Hong Kong
- The University of New South Wales press Limited
- Thermo Fisher Scientific Inc
- TrivarX Ltd
- U.S. Army Medical Research and Development Command
- Universal Biosensors Inc
- Universidade Feevale
- University of California Santa Cruz
- University of Central Florida
- University of Colorado
- University of Colorado Denver
- University of Edinburgh
- University of Florida
- University of Kentucky
- University of Massachusetts Lowell
- University of North Carolina at Chapel Hill
- University of North Dakota
- University of Queensland
- University of Sao Paulo
- University of Texas at Arlington
- University of Utah
- University of Washington
- UrSure Inc
- Vanderbilt University
- Vanteres Pte Ltd
- Vesynta Ltd
- Virginia Polytechnic Institute and State University
- Vyant Bio Inc (Inactive)
- Withings SA
- Zymeron Corp
For more information about this report visit https://www.researchandmarkets.com/r/x0k3l
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900